NPS RADAR January 2003NPS RADAR January 2003

NPS RADAR articles provide timely, independent, evidence-based assessment of new drugs, new PBS listings and research for health professionals.

Find out more about NPS RADAR.



Title Why read this
NPS RADAR January 2003 Professional publication - NPS RADAR - Complete issue NPS RADAR articles provide timely, independent, evidence-based assessment of new drugs, new PBS listings and research for health professionals.
Montelukast (Singulair) in asthma Professional publication - NPS RADAR - Review Reviews use of montelukast for frequent episodic or mild persistent asthma in children and adults as monotherapy or in combination with other antiasthmatic agents.
Who's right about thiazides: ALLHAT or ANBP2? Professional publication - NPS RADAR - Review Reviews and compares the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) and the Second Australian National Blood Pressure Study (ANBP2).

Complete list of all NPS RADAR content.

Find out more about NPS RADAR.

Keep track of what's new by RSS FeedKeep track of what's new by RSS Feed
RSS FeedRSS feed

Date published: 2003-01-01 00:00:00

Reasonable care is taken to provide accurate information at the date of creation. This information is not intended as a substitute for medical advice from a qualified health professional. Health professionals should rely on their own expertise and enquiries when providing medical advice or treatment. Where permitted by law, NPS disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer.

References to brands should not be taken as an endorsement by NPS.